Mason Freeman Cin Cor Pharma, Inc. (CINC) insider trading activity

CINC Quotes by TradingView

Mason Freeman is Chief Medical Officer of CinCor Pharma, Inc.. Currently has a direct ownership of 0 shares of CINC, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2023, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mason Freeman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2023
SELL
Sale (or disposition) back to the issuer
-
40,000 Reduced 100.0%
0 Common Stock
Feb 24 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
2,494 Reduced 5.87%
40,000 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 48.48%
42,500 Common Stock
Jun 10 2022
SELL
Open market or private sale
$91 $15.21 p/Share
6 Reduced 0.24%
2,494 Common Stock
Jan 11 2022
BUY
Open market or private purchase
$40,000 $16.0 p/Share
2,500 Added 50.0%
2,500 Common Stock
MF

Mason Freeman

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on CINC

Follow CinCor Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CINC shares.

Notify only if

Insider Trading

Get notified when an Cin Cor Pharma, Inc. insider buys or sells CINC shares.

Notify only if

News

Receive news related to CinCor Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CINC